@baucumlab.bsky.social

Excited to share that we just got a notice of award for our first lab R01. Excited to start work on this project. In the words of my 10-year old son - YESSIR.

Excited to share publication news for the lab. Our latest work describing a novel conditional neurabin knockout mouse line is available ASAP in ACS Chemical Neuroscience. Open Access version can be found here: pubs.acs.org/doi/10.1021/....

Proteomic Characterization of Striatal Neurabin Interactome and Its Sex Specific Impact on Motor Behavior

The striatum serves as the primary input nucleus of the basal ganglia. Reversible protein phosphorylation in the post synaptic density (PSD) of medium spiny neurons (MSNs) modulates inputs from striatal afferents. The context dependent regulation of PSD protein phosphorylation in direct-pathway medium spiny neurons (dMSNs) and indirect-pathway medium spiny neurons (iMSNs) works to differentially and synergistically impact striatal physiology and the execution of motor programs. An important regulator of PSD protein phosphorylation is protein phosphatase 1 (PP1), which obtains substrate specificity through the action of PP1 targeting proteins. While prior work has demonstrated the global and cell type-specific impact of the PP1 targeting protein, spinophilin, on striatal motor behaviors like the accelerating rotarod task and amphetamine sensitization, the role of its homologue, neurabin, is yet to be elucidated. Using proteomics approaches, we determined that striatal neurabin associates with pre and postsynaptic proteins that mediate glutamatergic synapse function. Moreover, we found that global loss of neurabin enhanced rotarod motor learning but had no impact on amphetamine sensitization. Interestingly, using novel conditional neurabin knockout mouse lines, we found that loss of neurabin in dMSNs, but not iMSNs, enhanced performance on the accelerating rotarod task and that these effects were specific for male mice. These data highlight neurabin’s particular importance to the striatal glutamatergic synapse and uncover a sex and cell type specific role for this synaptic protein in uniquely limiting skill motor learning but not psychomotor sensitization.

pubs.acs.org

Grant reviewed on Wednesday updated from Not Discussed to "Competitive-not discussed". I think in top half, but not top ~30%. A0 submission, so that is something. Hope that comments are addressable when I get summary statement. Looks like others like @nanopharmnc.bsky.social are in a similar boat

The 4th of my 4 grants this review round got a not discussed today. Glad I got at least 1 that got a 28th percentile, and will see how that goes, but I thought that at least one of my others would also have been discussed.

Had 2 grants reviewed this week. One ND and one 28th percentile. At least one was discussed and it was at NIGMS With the new system and given that NIGMS didn’t exclusively use percentiles previously anyway, will see if it has any chance. One more grant getting reviewed this week.

Two grants getting reviewed this week and one next week. I have had to wait almost a year for some of these to get reviewed as they were submitted as part of an at risk mechanism, which was removed when they were sent. I hope to get a good score, or at least discussed, but who knows.

Just saw my grant in commons that was supposed to be reviewed a month ago was rescheduled to December. Hopefully it is in the top 30% or whatever that gets Discussed. It is listed as a 2 day study section but I thought some study sections are going down to 1 day which is why they change triage line?

After 10 years, I am stepping down as chair of our department and we have an active search going on! Utah is a phenomenal place to live and work and it's been the honor of a lifetime chairing the department founded by Lou Goodman. #MedSky #Neuroskyence Repost! jobs.chronicle.com/job/37914733...

Chair of Pharmacology and Toxicology - Salt Lake City, Utah job with The University of Utah | 37914733

The University of Utah seeks a Chair of Pharmacology and Toxicology

jobs.chronicle.com

I got another ND on my NIH grant. While it’s hard to be too frustrated with the current state of things, this one was super frustrating as scored last time and thought the idea was much stronger and addressed the critiques well from the last round.

This happened to 3 of my 5 grants: assigned, de-assigned, study section canceled, study section rescheduled, grants de-assigned. One should get reviewed and I bet other will be de-assigned again. No chaos here.

DOGE is cutting funding for a badly-needed new VA medical center in Indianapolis. Denying healthcare to our veterans isn’t efficiency. It’s cruel. I’ve demanded that DOGE immediately reverse this dangerous decision.

Well the study section that was supposed to meet yesterday and today for one of my grants got an updated date of 04/22 on commons. I still don’t see it or any new ones in the federal register but not sure how long those take to post.

The 2nd of 5 study sections that I have grants being reviewed at got dreaded * - “Denotes this meeting did not take place as scheduled” by it. Federal register is supposedly opened up, but still the last study section posted was on 1/21, so will be 15-35 days at least for rescheduling, I bet.

OK #HoosierSky so this is happening Share amongst your peeps Those who are in science Those who like science Those who have been helped by science Those who value truth and facts Come hang with the cool kids and say hi to some rad scientists

Bild

Gene editing technology began by people studying salt marshes. Ozempic began by folks studying the venom of Gila Monsters. Support for basic science has empowered us to understand our world. Tethering it to applications health has transformed and saved countless lives.

The following post is my opinion and not a reflection of anyone else. I saw that 2 of my grants that were submitted in response to an “At Risk” mechanism were de-assigned from the study sections they were supposed to be reviewed at. They are currently not assigned to any study section. 1/6